Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xcell Biosciences develops advanced instrumentation and AI-driven platforms to enhance the performance, safety, and manufacturing of cell and gene-based therapies. Their flagship AVATAR™ system enables scalable expansion of therapeutic cells under conditions that mimic the solid tumor microenvironment. The company collaborates with biopharma partners such as AmplifyBio to advance engineered T-cell receptor therapies into clinical development—most notably an upcoming IND for HPV+ solid tumors using their technology. Their products are used from preclinical research through GMP-compliant clinical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xcell Biosciences.